Welcome to South West Healthcare
Leaders in healthcare, partners in wellbeing.
Browsing by Subject/keywords Molecularly Targeted Therapy
Showing results 1 to 4 of 4
Preview | Issue Date | Title / Name | Author(s) | Type |
| 2018 | Cardiotoxicity in advanced HER2 positive breast cancer in real world Australian patients receiving HER2-targeted therapy in the first-line setting | Conduit, C.; King, Rossa; De Boer, Richard; Gibbs, Peter; Lok, Sheau Wen, et al | Conference Paper | |
| 2019 | Clinical impact of tissue of origin testing and mutation profiling in the Solving Unknown Primary Cancer (SUPER) national prospective study: Experience of the first two years | Mileshkin, Linda R.; Sivakumaran, Tharani; Etemadmoghadam, Dariush; Tothill, Richard; Fellowes, Andrew, et al | Conference Paper | |
| Jun-2022 | DNA sequencing and gene-expression profiling assists in making a tissue of origin diagnosis in cancer of unknown primary | Posner, A.; Prall, Owen W. J.; Sivakumaran, Tharani; Etemadamoghadam, D.; Thio, N., et al | Journal Article | |
| 2021 | Real-world outcomes in patients with brain metastases secondary to HER2-positive breast cancer: An Australian multi-centre registry-based study | Tung, Iris; Moldovan, Cristina; Wong, Vanessa; De Boer, Richard; Gibbs, Peter, et al | Conference Paper | |